Mortalidad a 30 días posterior a la administración de quimioterapia sistémica en una unidad oncológica regional / Mortality within 30 days of receiving systemic chemotherapy at a regional oncology unit
Rev. méd. Chile
; 147(7): 887-890, jul. 2019. tab
Article
in Es
| LILACS
| ID: biblio-1058618
Responsible library:
CL1.1
ABSTRACT
Background:
The use of systemic chemotherapy has survival and palliation benefits in oncological patients. Mortality at 30 days after the administration of systemic chemotherapy is considered as a quality and safety indicator of oncological patient care. The international mortality threshold is 5%, which is the figure used to compare institutions.Aim:
To assess mortality at 30 days after the administration of ambulatory systemic chemotherapy in a regional referral center in adult cancer patients. Material andMethods:
Retrospective observational study of patients receiving ambulatory systemic chemotherapy in the oncology service of a regional public hospital during 2018. The 30-day mortality rate was calculated. Demographic characteristics, baseline disease and the treatment received were recorded.Results:
During the study period, 690 patients received ambulatory systemic chemotherapy. Chemotherapy was palliative in 76% of patients and 53% received a first line treatment. Seventeen (2.5%) died within 30 days of treatment administration. Nine deaths (52.9%) were definitely related to treatment and sepsis was the most frequent cause.Conclusions:
Our mortality rates are similar to international data. This type of audit reviews local outcomes and identifies factors contributing to mortality aiming to improve standards of care.Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Neoplasms
/
Antineoplastic Agents
Type of study:
Guideline
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Es
Journal:
Rev. méd. Chile
Journal subject:
MEDICINA
Year:
2019
Document type:
Article
Affiliation country:
Chile